Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...
AllAfrica.com7 小时
Africa: Breast Cancer - Why It's Difficult to Treat and What New Approaches Are On the Horizon
Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also particularly challenging to treat. Physiologist Anna-Mart ...
SABC8 小时
Breast cancer: why it’s difficult to treat, new approaches on horizon
Triple-negative breast cancer (TNBC): The breast tissue lacks estrogen receptors, progesterone receptors, and HER2 protein receptors that control how cells grow and divide. Triple-negative breast ...
Targeted Oncology6 小时
FDA Clears IND of ADRX-0405, Next-Gen ADC, in Solid Tumors
ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...
Pharmabiz13 小时
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising ...
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat: Taipei, Taiwan Tuesday, October 22, 202 ...
emjreviews.com16 小时
Heterogeneity of Inflammatory Processes and Pathways Driving Chronic Obstructive Pulmonary ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
emjreviews.com16 小时
Bronchiectasis Exacerbations: Are We Doing Everything We Can?
The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...